New Enterprise Associates 14, L.P. 13D and 13G filings for Adaptimmune Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-04-02 8:38 pm Unchanged |
2024-04-01 | 13D | Adaptimmune Therapeutics plc ADAP |
New Enterprise Associates 14, L.P. | 102,478,672 6.700% |
0 (Unchanged) |
Filing |
| 2023-03-30 5:13 pm Purchase |
2023-03-05 | 13D | Adaptimmune Therapeutics plc ADAP |
New Enterprise Associates 14, L.P. | 102,478,672 10.300% |
3,556,804 (+3.60%) |
Filing |